Skip to main content
Swapna Thota, MD, Hematology, Memphis, TN

Swapna Thota MD

Hematologic Oncology


Physician

Join to View Full Profile
  • UT Regional One Physicians, Inc877 Jefferson AvenueMemphis, TN 38103

Dr. Thota is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2013 - 2017
  • Osmania Medical College NTR UHS
    Osmania Medical College NTR UHSClass of 2007
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2017 - 2020
  • OH State Medical License
    OH State Medical License 2010 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study
    Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid...
    Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...
    Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Swapna Thota, MD, a Hematologist with Roswell Park Comprehensive Cancer Center
    Swapna Thota, MD, a Hematologist with Roswell Park Comprehensive Cancer CenterJune 11th, 2020
  • Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic Cancers
    Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic CancersMay 29th, 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: